ATE226832T1 - Mittel zur arzneistoffverabreichung durch iontophorese - Google Patents

Mittel zur arzneistoffverabreichung durch iontophorese

Info

Publication number
ATE226832T1
ATE226832T1 AT97110139T AT97110139T ATE226832T1 AT E226832 T1 ATE226832 T1 AT E226832T1 AT 97110139 T AT97110139 T AT 97110139T AT 97110139 T AT97110139 T AT 97110139T AT E226832 T1 ATE226832 T1 AT E226832T1
Authority
AT
Austria
Prior art keywords
iontophoresis
drug
humectant
agent
drug administration
Prior art date
Application number
AT97110139T
Other languages
English (en)
Inventor
Naruhito Higo
Hirotoshi Adachi
Kenji Mori
Katsumi Iga
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE226832T1 publication Critical patent/ATE226832T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97110139T 1996-06-20 1997-06-20 Mittel zur arzneistoffverabreichung durch iontophorese ATE226832T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18148096 1996-06-20

Publications (1)

Publication Number Publication Date
ATE226832T1 true ATE226832T1 (de) 2002-11-15

Family

ID=16101500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97110139T ATE226832T1 (de) 1996-06-20 1997-06-20 Mittel zur arzneistoffverabreichung durch iontophorese

Country Status (5)

Country Link
EP (1) EP0813879B1 (de)
CN (1) CN1171269A (de)
AT (1) ATE226832T1 (de)
CA (1) CA2208332A1 (de)
DE (1) DE69716676T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081030C (zh) * 1996-02-07 2002-03-20 立德化学株式会社 含有曲尼司特的外用制剂及其制备方法
EP0922467A3 (de) 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
US7848801B2 (en) 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
JP5383497B2 (ja) 2006-12-01 2014-01-08 Ｔｔｉ・エルビュー株式会社 装置、例として経皮送達装置に給電し且つ／又は当該装置を制御するシステム及び装置
KR101656537B1 (ko) 2008-06-19 2016-09-09 에르테에스 로만 테라피-시스테메 아게 양이온성 활성제의 경피 전달용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
JPH07501103A (ja) * 1991-11-12 1995-02-02 ネペラ　インコーポレイテッド 長い使用寿命をもつ接着性ヒドロゲルおよびその調製法
EP0747092B1 (de) * 1995-06-09 2003-12-03 Hisamitsu Pharmaceutical Co., Inc. Matrix für Iontophorese

Also Published As

Publication number Publication date
EP0813879A3 (de) 1998-10-14
EP0813879A2 (de) 1997-12-29
DE69716676T2 (de) 2003-03-20
DE69716676D1 (de) 2002-12-05
EP0813879B1 (de) 2002-10-30
CA2208332A1 (en) 1997-12-20
CN1171269A (zh) 1998-01-28

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE69833000D1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DE69630918D1 (de) Matrix für Iontophorese
DE69401945T2 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
ES2116421T3 (es) Composiciones que contienen aminoacidos mono o polihidroxilados para el tratamiento de la diabetes no insulino-dependiente.
EA199900448A1 (ru) Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos
BR9813284B1 (pt) aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
DE69535556D1 (de) Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
DE69833684D1 (de) Antioxidierende stabilisierungssysteme für pharmazeutische formulierungen
ATE239498T1 (de) Entzündungshemmende zusammensetzung
DE69805983T2 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
AU2101800A (en) Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
EA200000165A1 (ru) Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
DE69501105T2 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
ATE226832T1 (de) Mittel zur arzneistoffverabreichung durch iontophorese
BR9001484A (pt) Composicao inseticida e acaricida com efeito aperfeicoado,processo para aperfeicoar o efeito de uma substancia ativa inseticida
GEP20094648B (en) Anti-parasiticidal composition
ATE208144T1 (de) Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE294568T1 (de) Zusammensetzung zur behandlung von verbrennungen
EP2078525A3 (de) Behandlung der Tuberkulose mit immunmodulatorischen Verbindungen
DE69820511D1 (de) Aminosäurederivate und diese enthaltende Zusammensetzungen zur Hemmung von aktivem Sauerstoff
ATE235909T1 (de) Biologisch kompatible und biologisch abbaubare zubereitungen enthaltend hyaluronsäure und deren derivate zur behandlung von geschwüren im verdauungsapparat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties